IRadimed Corporation Provides Earnings Guidance for the Full Year and First Quarter of 2016; Revises Revenue Guidance for the Fourth Quarter of 2015
For the first quarter of 2016, the company expects to report revenue of $9.0 million to $9.1 million and non-GAAP diluted earnings per share of $0.17 to $0.18, an increase of 21% to 29% over the first quarter 2015 non-GAAP diluted earnings per share of $0.14.
The company expects to report revenue of approximately $8.8 million for the fourth quarter of 2015, exceeding the company's guidance of $8.5 million to $8.6 million.